DYADIC INTERNATIONAL INC Payments to Acquire Held-to-maturity Securities
DYADIC INTERNATIONAL INC (DYAI) reported Payments to Acquire Held-to-maturity Securities of $1.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2026-08-12
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for the quarter ending 2026-06-30 was $726.88K, a 76.56% decline year-over-year.
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for the quarter ending 2026-03-31 was $566.55K, a 61.17% decline year-over-year.
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for the quarter ending 2025-12-31 was $861.42K, a 37.20% decline year-over-year.
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for the quarter ending 2025-09-30 was $530.57K, a 57.11% decline year-over-year.
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for fiscal 2025 was $5.95M, a 18.94% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for fiscal 2024 was $7.34M, a 145.10% increase from fiscal 2023.
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for fiscal 2023 was $3.00M, a 69.64% decline from fiscal 2022.
- DYADIC INTERNATIONAL INC payments to acquire held-to-maturity securities for fiscal 2022 was $9.87M, a 12.54% decline from fiscal 2021.
| Period end | Payments to Acquire Held-to-maturity Securities 3 month | Payments to Acquire Held-to-maturity Securities 3 month as first filed | Payments to Acquire Held-to-maturity Securities 6 month | Payments to Acquire Held-to-maturity Securities 9 month | Payments to Acquire Held-to-maturity Securities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $726.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.29M 10-Q · filed 2026-08-12 | $2.15M derived: sum of 3 quarters · filed 2026-08-12 | $2.69M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $566.55K 10-Q · filed 2026-05-13 | $1.43M derived: sum of 2 quarters · filed 2026-05-13 | $1.96M derived: sum of 3 quarters · filed 2026-05-13 | $5.06M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $861.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.39M derived: sum of 2 quarters · filed 2026-03-25 | $4.49M derived: sum of 3 quarters · filed 2026-08-12 | $5.95M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $530.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.63M derived: sum of 2 quarters · filed 2026-08-12 | $5.09M 10-Q · filed 2025-11-12 | $6.46M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.56M 10-Q · filed 2026-08-12 | $5.93M derived: sum of 3 quarters · filed 2026-08-12 | $7.17M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $1.46M 10-Q · filed 2026-05-13 | $2.83M derived: sum of 2 quarters · filed 2026-05-13 | $4.07M derived: sum of 3 quarters · filed 2026-05-13 | $7.19M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.61M derived: sum of 2 quarters · filed 2026-03-25 | $5.73M derived: sum of 3 quarters · filed 2026-03-25 | $7.34M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.36M derived: sum of 2 quarters · filed 2025-11-12 | $5.97M 10-Q · filed 2025-11-12 | $6.72M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $4.73M 10-Q · filed 2025-08-13 | $5.48M derived: sum of 3 quarters · filed 2025-08-13 | $5.75M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $1.62M 10-Q · filed 2025-05-14 | $2.36M derived: sum of 2 quarters · filed 2025-05-14 | $2.63M derived: sum of 3 quarters · filed 2025-05-14 | $3.89M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $744.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $1.02M derived: sum of 2 quarters · filed 2025-03-26 | $2.28M derived: sum of 3 quarters · filed 2025-03-26 | $3.00M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $273.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.53M derived: sum of 2 quarters · filed 2024-11-12 | $2.25M 10-Q · filed 2024-11-12 | $3.63M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.98M 10-Q · filed 2024-08-13 | $3.36M derived: sum of 3 quarters · filed 2024-08-13 | $5.67M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $719.77K 10-Q · filed 2024-05-14 | $2.10M derived: sum of 2 quarters · filed 2024-05-14 | $4.41M derived: sum of 3 quarters · filed 2024-05-14 | $5.57M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.69M derived: sum of 2 quarters · filed 2024-03-28 | $4.85M derived: sum of 3 quarters · filed 2024-03-28 | $9.87M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.47M derived: sum of 2 quarters · filed 2023-11-08 | $8.49M 10-Q · filed 2023-11-08 | $8.49M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.18M 10-Q · filed 2023-08-09 | $6.18M derived: sum of 3 quarters · filed 2023-08-09 | $6.18M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $5.02M 10-Q · filed 2023-05-10 | $5.02B 10-Q · filed 2022-05-12 | $5.02M derived: sum of 2 quarters · filed 2023-05-10 | $5.02M derived: sum of 3 quarters · filed 2023-05-10 | -$11.27B derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | -$11.27B derived: sum of 3 quarters · filed 2023-03-29 | $11.28M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$11.27B derived: sum of 2 quarters · filed 2022-11-10 | $11.28M 10-Q · filed 2022-11-10 | $14.25M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$11.27B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $11.28M 10-Q · filed 2022-08-10 | $14.25M derived: sum of 3 quarters · filed 2022-08-10 | $14.25M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $11.28B 10-Q · filed 2022-05-12 | $11.28M 10-Q · filed 2021-05-13 | $11.29B derived: sum of 2 quarters · filed 2022-05-12 | $11.29B derived: sum of 3 quarters · filed 2022-05-12 | $11.29B derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $2.96M derived: sum of 2 quarters · filed 2022-03-29 | $5.99M derived: sum of 3 quarters · filed 2022-03-29 | $17.64M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.02M derived: sum of 2 quarters · filed 2021-11-10 | $14.68M 10-Q · filed 2021-11-10 | $24.71M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $14.68M 10-Q · filed 2021-08-12 | $24.71M derived: sum of 3 quarters · filed 2021-08-12 | $38.72M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $11.65M 10-Q · filed 2021-05-13 | $21.68M derived: sum of 2 quarters · filed 2021-05-13 | $35.70M derived: sum of 3 quarters · filed 2021-05-13 | $46.08M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $24.04M derived: sum of 2 quarters · filed 2021-03-30 | $34.42M derived: sum of 3 quarters · filed 2021-03-30 | $47.62M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $14.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $24.39M derived: sum of 2 quarters · filed 2020-11-12 | $37.59M 10-Q · filed 2020-11-12 | $48.00M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $10.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $23.57M 10-Q · filed 2020-08-13 | $33.99M derived: sum of 3 quarters · filed 2020-08-13 | $42.99M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $13.19M 10-Q · filed 2020-05-14 | $23.61M derived: sum of 2 quarters · filed 2020-05-14 | $32.60M derived: sum of 3 quarters · filed 2020-05-14 | $45.16M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $19.41M derived: sum of 2 quarters · filed 2020-03-30 | $31.97M derived: sum of 3 quarters · filed 2020-03-30 | $49.73M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $21.56M derived: sum of 2 quarters · filed 2019-11-13 | $39.32M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $12.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $30.32M 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $17.76M 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $51.46M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |